Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human GFR alpha-2 Fc Chimera Protein

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity

Supplier:  R&D Systems™ 613FR100

Catalog No. 613FR100


Add to Cart
This item is not returnable. View return policy

Description

Description

The Recombinant Human GFR alpha-2 Fc Chimera Protein is derived from NS0. The Recombinant Human GFR alpha-2 Fc Chimera Protein has been validated for the following applications: Binding Activity.
Specifications

Specifications

Lyophilized from a 0.2μm filtered solution in PBS.
74 kDa (monomer)
100μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Recombinant
2675
GFR alpha-2/GDNF R alpha-2 Fc Chimera
Mouse myeloma cell line,NS0-derived human GFR alpha-2/GDNF R alpha-2 protein, (N-terminus) Human GFR alpha-2 (Ser22-Ser441) Accession &Num; O00451 DIEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus)
Unconjugated
95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit